With your own knowledge and the help of the following document:

Document 1 (Title: Diagnostic Approach to Preeclampsia): Hypertensive disorders complicate 5-10% of pregnancies and contribute significantly to maternal and perinatal morbidity and mortality worldwide. Preeclampsia, a pregnancy-specific multisystem disorder characterized by hypertension and end-organ dysfunction after 20 weeks gestation, affects approximately 3-5% of pregnancies. Early detection through regular prenatal assessments remains crucial for optimizing maternal and fetal outcomes. The contemporary diagnostic criteria for preeclampsia focus on both blood pressure parameters and evidence of maternal organ dysfunction. Hypertension, defined as systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg on two occasions at least four hours apart, represents the fundamental requirement. Proteinuria, historically considered mandatory for diagnosis, is now recognized as just one of several possible indicators of end-organ involvement. Quantification of urinary protein excretion through 24-hour urine collection remains the gold standard assessment, with significant proteinuria defined as ≥300 mg in 24 hours or a protein/creatinine ratio ≥0.3 mg/dL in a random sample. Other laboratory evaluations, including liver function tests and coagulation studies, help assess hepatic involvement and potential HELLP syndrome (hemolysis, elevated liver enzymes, low platelets). Leukocytosis may occur but lacks specificity for preeclampsia. Clinical manifestations often include rapid weight gain and generalized edema, particularly facial and periorbital, distinguishing it from dependent edema commonly observed in normal pregnancy. Progressive symptoms including headache, visual disturbances, and epigastric pain suggest impending eclampsia, necessitating urgent intervention.
Document 2 (Title: Etiology and Pathophysiology of Spontaneous Abortion): First-trimester pregnancy loss, clinically defined as spontaneous abortion before 13 weeks gestation, affects approximately 10-20% of clinically recognized pregnancies, with significantly higher rates when considering pre-clinical losses. While multiple etiologies contribute to early pregnancy failure, chromosomal abnormalities represent the predominant cause, accounting for approximately 50-60% of first-trimester losses. These cytogenetic aberrations predominantly arise from errors during gametogenesis or early embryonic divisions, with advancing maternal age significantly increasing risk, particularly for aneuploidies. Autosomal trisomies constitute the most common chromosomal abnormality, with trisomy 16 appearing most frequently, followed by trisomies 22, 21, and 18. Polyploidy, particularly triploidy, represents another significant cytogenetic abnormality, often associated with partial molar pregnancies. Structural chromosomal abnormalities, including translocations and inversions, contribute less frequently to sporadic losses but become increasingly significant in recurrent pregnancy loss. The pathophysiological mechanism typically involves disrupted embryonic development due to altered gene dosage, ultimately culminating in embryonic demise and subsequent expulsion. Clinical manifestations follow a characteristic sequence, beginning with embryonic death, followed by cessation of hormone production, declining progesterone and human chorionic gonadotropin levels, destabilization of the decidual-trophoblastic interface, and finally uterine contractions with expulsion of products of conception. Alternative etiologies include maternal factors such as endocrine disorders (thyroid dysfunction, uncontrolled diabetes), uterine anatomic abnormalities (septate uterus, submucosal leiomyomas), and thrombophilic conditions (antiphospholipid syndrome, inherited thrombophilias). Immunological factors, particularly alloimmune mechanisms, remain controversial and incompletely understood. External factors such as maternal exposure to toxins, including alcohol, tobacco, and certain medications, may increase risk, albeit less significantly than chromosomal factors. Physical trauma rarely causes early pregnancy loss unless associated with direct uterine injury or significant maternal hemodynamic compromise. Comprehensive evaluation for specific etiology typically follows recurrent pregnancy loss (traditionally defined as three or more consecutive losses), though contemporary approaches often initiate investigation after two losses, particularly in women of advanced reproductive age.
Document 3 (Title: Thermoregulatory and Cardiovascular Responses to Bathing in Infancy): Syncope during infant bathing represents an uncommon but potentially concerning phenomenon that has generated clinical interest regarding its pathophysiological mechanisms and relationship to other vasovagal conditions. Case series document infants, typically between 4-12 months of age, experiencing sudden pallor, limpness, and brief loss of consciousness during or immediately following water immersion, with rapid and complete recovery. These episodes bear striking resemblance to the clinical presentation of water-induced urticaria, a rare physical urticaria subtype characterized by cutaneous and sometimes systemic reactions following water contact. Overlapping features include the temporal relationship to water exposure, absence of urticarial lesions in some cases, and potential for cardiovascular manifestations including hypotension. Pathophysiological investigation into bathing-related syncope reveals several potential mechanisms. Thermal stress from water immersion triggers complex cardiovascular adaptations, with sudden exposure to warm water inducing peripheral vasodilation and potential venous pooling, reducing effective circulating volume. Concurrent vagal stimulation from temperature-sensitive receptors may precipitate bradycardia, further compromising cerebral perfusion. Autonomic regulation remains incompletely developed in infants, potentially predisposing them to exaggerated vasovagal responses to thermal stimuli. The similarity to water-induced urticaria extends beyond clinical presentation to proposed mechanisms, which include water-induced histamine release through direct mast cell activation or osmotic changes altering cell membrane permeability. While classic water-induced urticaria typically presents with visible cutaneous manifestations, variant forms with predominantly cardiovascular manifestations have been documented. Diagnostic evaluation of affected infants typically includes cardiac assessment to exclude structural or rhythm disturbances, with electroencephalography considered if atypical features suggest seizure activity. Management focuses primarily on preventive measures including temperature modification, maintaining appropriate environmental warmth, limiting immersion duration, and ensuring adequate hydration. Some cases demonstrate responsiveness to antihistamine prophylaxis, providing further evidence for a shared mechanism with physical urticarias. Long-term prognosis appears favorable, with many cases resolving spontaneously with maturation of autonomic regulatory mechanisms, though longitudinal studies remain limited.

Answer the following multiple-choice question.
Question: A 23-year-old pregnant woman at 22 weeks gestation presents with burning upon urination. She states it started 1 day ago and has been worsening despite drinking more water and taking cranberry extract. She otherwise feels well and is followed by a doctor for her pregnancy. Her temperature is 97.7°F (36.5°C), blood pressure is 122/77 mmHg, pulse is 80/min, respirations are 19/min, and oxygen saturation is 98% on room air. Physical exam is notable for an absence of costovertebral angle tenderness and a gravid uterus. Which of the following is the best treatment for this patient?
Options:
A. Ampicillin
B. Ceftriaxone
C. Doxycycline
D. Nitrofurantoin

Respond strictly in valid JSON format as follows:
{"answer_choice": "A"} ← if A is the answer
Output only the JSON object. Do not include any explanation, commentary, markdown, or extra text.